BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/11/2026 3:41:42 AM | Browse: 57 | Download: 262
 |
Received |
|
2025-08-04 06:00 |
|
Peer-Review Started |
|
2025-08-04 06:00 |
|
First Decision by Editorial Office Director |
|
2025-08-11 07:17 |
|
Return for Revision |
|
2025-08-11 07:17 |
|
Revised |
|
2025-08-24 17:43 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-03 02:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-03 09:42 |
|
Articles in Press |
|
2025-12-03 09:42 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-04 00:10 |
|
Publish the Manuscript Online |
|
2026-02-11 03:41 |
| ISSN |
2150-5349 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Artificial intelligence in the management of inflammatory bowel disease: What’s next?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Anthony J Bilotta, Jennifer A Trebilcock, Nicholas J Hebda, Charanpreet K Sasan, Katherine M Cooper and Abbas H Rupawala |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Katherine M Cooper, MD, Department of Medicine, UMass Chan Medical School, 55 Lake Ave North, Worcester, MA 01655, United States. katherine.cooper@umassmed.edu |
| Key Words |
Inflammatory bowel disease; Ulcerative colitis; Crohn’s disease; Artificial intelligence; Machine learning; Deep learning |
| Core Tip |
Inflammatory bowel disease (IBD) is a chronic relapsing-remitting autoimmune disorder of the gastrointestinal tract. The management of IBD is complex and relies on subjective interpretation of invasive and non-invasive assessments to guide therapeutic decisions. Artificial intelligence (AI) is emerging as a potential tool to standardize the assessment of IBD and personalize therapeutic selection. This article highlights recent advances in AI in IBD with a focus on endoscopy, non-invasive imaging, histology, AI chatbots, therapeutic prediction models and current barriers to widespread implementation of AI in clinical practice. |
| Publish Date |
2026-02-11 03:41 |
| Citation |
Bilotta AJ, Trebilcock JA, Hebda NJ, Sasan CK, Cooper KM, Rupawala AH. Artificial intelligence in the management of inflammatory bowel disease: What’s next? World J Gastrointest Pharmacol Ther 2026; 17(1): 112640 |
| URL |
https://www.wjgnet.com/2150-5349/full/v17/i1/112640.htm |
| DOI |
https://dx.doi.org/10.4292/wjgpt.v17.i1.112640 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
